Balyasny Asset Management
SRTA

Balyasny Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Balyasny Asset Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-160,863
Closed -$814K – 3095
2025
Q3 		$814K Buy
+160,863
New +$711K ﹤0.01% 2205
2025
Q1 		– Sell
-14,600
Closed -$62K – 2805
2024
Q4 		$62K Buy
+14,600
New +$55.6K ﹤0.01% 2629
2022
Q4 		– Sell
-14,033
Closed -$57K – 2794
2022
Q3 		$57K Buy
+14,033
New +$72.1K ﹤0.01% 2461
2022
Q2 		– Sell
-36,207
Closed -$307K – 2759
2022
Q1 		$307K Buy
+36,207
New +$254K ﹤0.01% 1917

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Balyasny Asset Management's SRTA Position: Q4 2025 in Review

Balyasny Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 160,863 shares — an estimated $814K sold.

Balyasny Asset Management first reported a position in SRTA in Q1 2022 and held it in 4 quarters. The position peaked at $814K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • Balyasny Asset Management reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 160,863 Strata Critical Medical Inc shares in Q4 2025, an estimated $814K.
  • Balyasny Asset Management first reported a position in Strata Critical Medical Inc in Q1 2022 and held it in 4 quarters.
  • Balyasny Asset Management's Strata Critical Medical Inc position peaked at $814K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.